1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selection of tumor antigens as targets for immune attack using immunohistochemistry: Protein antigens
    Journal Article

    Zhang, S.; Zhang, H. S.; Cordon-Cardo, C.; Ragupathi, G.; Livingston, P. O.
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases
    Journal Article

    Zhang, H.; Zhang, S.; Cheung, N. K. V.; Ragupathi, G.; Livingston, P. O.
    Cancer Research (1998)

    Fulltext@MSK | Save
  • Immunogenicity of synthetic conjugates of Lewis(y) oligosaccharide with proteins in mice: Towards the design of anticancer vaccines
    Journal Article

    Kudryashov, V.; Kim, H. M.; Ragupathi, G.; Danishefsky, S. J.; Livingston, P. O.; Lloyd, K. O.
    Cancer Immunology, Immunotherapy (1998)

    Fulltext@MSK | Save
  • Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parameters
    Journal Article

    Maguire, H. C. Jr; Berd, D.; Lattime, E. C.; McCue, P. A.; Kim, S.; Chapman, P. B.; Mastrangelo, M. J.
    Cancer Biotherapy and Radiopharmaceuticals (1998)

    Fulltext@MSK | Save
  • Phase I trial with GD3-lactone-KLH conjugate and immunological adjuvant QS-21 vaccine with malignant melanoma
    Meeting Abstract

    Ragupathi, G.; Meyers, M.; Adluri, S.; Ritter, G.; Livingston, P. O.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Antibody response to vaccination of breast cancer patients with MUC1-KLH plus QS-21 is restricted to the APDTRPA epitope
    Meeting Abstract

    Livingston, P.; Adluri, S.; Ramnath, V.; Zhang, S.; Ragupathi, G.; Gilewski, T.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Use of ELISPOT assay to detect T cells against mutated K-ras peptides in mice
    Meeting Abstract

    Sun, Q.; Chapman, P. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Vaccination of high-risk breast cancer patients (PTS) with no evidence of disease (NED) with sialyl TN cluster (sTn(c)) - Keyhole limpet hemocyanin (KLH) conjugate plus QS-21
    Meeting Abstract

    Dickler, M.; Gilewski, T.; Ragupathi, G.; Adluri, R.; Chin, J.; Koganty, R.; Longenecker, M.; Houghton, A.; Norton, L.; Livingston, P.
    Breast Cancer Research and Treatment (1997)

    Fulltext@MSK | Save
  • Anti-melanoma effects of R24, a monoclonal antibody against GD(3) ganglioside
    Journal Article

    Nasi, M. L.; Meyers, M.; Livingston, P. O.; Houghton, A. N.; Chapman, P. B.
    Melanoma Research (1997)

    Fulltext@MSK | Save
  • Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma
    Journal Article

    Soiffer, R. J.; Chapman, P. B.; Murray, C.; Williams, L.; Unger, P.; Collins, H.; Houghton, A. N.; Ritz, J.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save